The Use of Homologous Antigen in the Serological Diagnosis of Brucellosis Caused by Brucella melitensis

Similar documents
Bovine Brucellosis Control of indirect ELISA kits

Efficacy of Brucella abortus vaccine strain RB51. compared to the reference vaccine Brucella abortus

Standardisation of an indirect enzyme linked. of Brucella antibodies in milk from water buffalo

An ELISA for the evaluation of gamma interferon. production in cattle vaccinated with Brucella abortus

Sera from 2,500 animals from three different groups were analysed:

Use of the complement fixation and brucellin skin tests to identify cattle vaccinated with Brucella abortus strain RB51

DISEASE DETECTION OF BRUCELLOSIS IN GOAT POPULATION IN NEGERI SEMBILAN, MALAYSIA. Abstract

and other serological tests in experimentally infected cattle

Immunological Response of Awassi Sheep to Conjunctival Vaccination against Brucellosis Disease in Mount Lebanon

A rapid test for evaluating B. melitensis infection prevalence in an Alpine ibex (Capra ibex) reservoir in the French Alps

Surveillance of animal brucellosis

OIE Reference Laboratory Reports Activities

Procedures for the Taking of Preventive and Eradication Measures of Brucellosis for Swine

EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Unit G5 - Veterinary Programmes

COMMISSION (2003/708/EC)

Procedures for the Taking of Prevention and Eradication Measures of Brucellosis in Bovine Animals

Surveillance of Brucella Antibodies in Camels of the Eastern Region of Abu Dhabi, United Arab Emirates

Vaccine. Diagnostic and Vaccine Chapter. J.H. Wolfram a,, S.K. Kokanov b, O.A. Verkhovsky c. article info abstract

Article 3 This Directive shall enter into force on the day of its publication in the Official Journal of the European

Cross reactivity in serological tests for brucellosis: a comparison of immune response of. and Yersinia enterocolitica O:9 vs Brucella spp.

COMMISSION IMPLEMENTING REGULATION (EU)

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT

2012 Work Programme of the

Implementation of Bovine and Small Ruminant s Brucellosis Eradication Programmes in Portugal PAFF Standing Committee Brussels, 8 June 2017

COMMISSION. (Text with EEA relevance) (2009/712/EC)

Classificatie: intern

OIE Reference Laboratory Reports Activities

ENZYME IMMUNOASSAYS FOR THE DIAGNOSIS OF BOVINE BRUCELLOSIS: TRIAL IN LATIN AMERICA

Annual Report Norwegian Veterinary Institute. in Norway Norwegian Veterinary Institute

Comparative Evaluation of Microagglutination Test and Serum Agglutination Test as Supplementary Diagnostic Methods for Brucellosis

OIE laboratory network on diseases of camelids Final report

Survey of the seroprevalence of brucellosis in ruminants in Kosovo

The role of the IZS A&M as OIE Collaborating Centre on veterinary training, epidemiology, food safety and animal welfare Barbara Alessandrini

(Non-legislative acts) DECISIONS

Revaccination with a reduced dose of Brucella abortus strain 19 vaccine of breeding cows in the Pampas region of Argentina

2015 Work Programme of the

II. MATERIALS AND METHODS

COMPARISON OF DIFFERENT SEROLOGICAL ASSAYS FOR THE DIFFERENTIAL DIAGNOSIS OF BRUCELLOSIS

The surveillance programme for Brucella abortus in cattle in Norway in 2017

COMMISSION IMPLEMENTING DECISION

Authors: Theresia Abdoel, Isabel Travassos Dias, Regina Cardoso, Henk L. Smits

Import Health Standard. For. Bovine Semen

EUROPEAN REFERENCE LABORATORY (EU-RL) FOR BOVINE TUBERCULOSIS WORK-PROGRAMME PROPOSAL Version 2 VISAVET. Universidad Complutense de Madrid

CAPRINE AND OVINE BRUCELLOSIS (excluding Brucella ovis)

Background 1 st, 2 nd and 3 rd FAO-APHCA/OIE Regional Workshop on Brucellosis Diagnosis and Control with an Emphasis on Brucella melitensis (in

Seroprevalence of human brucellosis in Erbil city

Hemolysis Test for Cattle Vaccinated and Infected with

SIGNIFICANT DISEASES OF CAMELIDAE. Serological tests

The surveillance and control programme

Terrestrial and Aquatic Manuals and the mechanism of standard adoption

COMMISSION DELEGATED REGULATION (EU)

Official Journal of the European Union

Radial Immunodiffusion Test with a Brucella Polysaccharide Antigen for Differentiating Infected from Vaccinated Cattle

(Text with EEA relevance)

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

The Diagnosis of Brucellosis in cattle, sheep, goats & pigs What is needed?

DISEASE SITUATION AND ACTIVITIES

Overview of animal and human brucellosis in EU: a controlled disease?

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Country Report Malaysia. Norazura A. Hamid Department of Veterinary Services, Malaysia

Brucellosis situation in Mongolia and Result of Bovine Brucellosis Proficiency Test

Manual for Reporting on Zoonoses, Zoonotic Agents and Antimicrobial Resistance in the framework of Directive 2003/99/EC

L 210/36 Official Journal of the European Union DECISIONS COMMISSION

The use of different Brucella vaccines for protection against Brucella melitensis infection in cattle.

Seroprevalence of small ruminant brucellosis in Werer Agricultural Research Center, Afar Region, North East Ethiopia

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Data were analysed by SPSS, version 10 and the chi-squared test was used to assess statistical differences. P < 0.05 was considered significant.

Competent Authority response to the report recommendations received on 24 August 2016

Title: Spatial distribution and risk factors of Brucellosis in Iberian wild ungulates

(Non-legislative acts) REGULATIONS

The surveillance programme for Brucella melitensis in small ruminants in Norway in 2016

Seroprevalence Studies of Brucellosis among Human using Different Serological Tests

Indirect Enzyme-Linked Immunosorbent Assay for Detection of Brucella melitensis-specific Antibodies in Goat Milk

Inactivation of Burkholderia mallei in equine serum for laboratory use.

OIE Reference Laboratory Reports Activities

Cercetări bacteriologice, epidemiologice şi serologice în bruceloza ovină ABSTRACT

COMMISSION REGULATION (EU)

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

Country Report on Disease Situation and Laboratory Works Nepal. Dr Pragya Koirala Senior Veterinary Officer Central Veterinary Laboratory Nepal

FESASS General Assembly, 22 September 2011, Brussels. Financial aspects of infectious animal disease control and eradication

The benefits of I&R for cats and dogs EU Parliament - Strasbourg 8 September Dr. Paolo Dalla Villa

OIE Reference Laboratory Reports Activities

Improving consumer protection against zoonotic diseases Phase II Project No: EuropeAid/133990/C/SER/AL

Brucellosis among ruminants in some districts of Bangladesh using four conventional serological assays

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

Peste des Petits Ruminants. Articles of the OIE Terrestrial Manual and Terrestrial Code related to PPR. Joseph Domenech, OIE

ANNEX. to the COMMISSION IMPLEMENTING DECISION

International movement of pet animals

Received 26 September 2006/Returned for modification 8 November 2006/Accepted 2 January 2007

Official Journal of the European Union L 280/5

Enzootic abortion in sheep and its economic consequences

Questions and Answers on TSE in sheep and goats

COMMISSION DELEGATED REGULATION (EU) /... of XXX

Risk assessment of the re-emergence of bovine brucellosis/tuberculosis

The surveillance and control programme for Brucella melitensis in small ruminants in Norway

COMPARATIVE EVALUATION OF COMMERCIAL SERODIAGNOSTIC TESTS FOR THE SEROPREVALENCE STUDY OF BRUCELLOSIS IN STRAY DOGS IN BANGLADESH

A STUDY ON THE SEROPREVALENCE OF BRUCELLOSIS IN HUMAN AND GOAT POPULATIONS OF DISTRICT BHIMBER, AZAD JAMMU AND KASHMIR ABSTRACT

Transcription:

J. Vet. Med. B 52, 75 81 (25) Ó 25 Blackwell Verlag, Berlin ISSN 931 1793 Istituto Zooprofilattico Sperimentale dell Abruzzo e del Molise ÔG. CaporaleÕ, Campo Boario, Teramo, Italy The Use of Homologous Antigen in the Serological Diagnosis of Brucellosis Caused by Brucella melitensis M. Tittarelli 1,2,A.Giovannini 1,A.Conte 1,M.Di Ventura 1,D.Nannini 1 and V. Caporale 1 Address of authors: 1 Istituto Zooprofilattico Sperimentale dell Abruzzo e del Molise ÔG. CaporaleÕ, Campo Boario, 641 Teramo, Italy; 2 Corresponding author: E-mail: m.tittarelli@izs.it With 8 figures and 2 tables Received for publication September 21, 24 Summary In the European Union the serological diagnosis of brucellosis caused by Brucella melitensis is performed using the heterologous antigen of B. abortus S99. The possible higher sensitivity or ability of an early detection of antibodies by a homologous antigen may prove very useful in the final phases of an eradication programme. Results obtained in sheep experimentally infected by B. melitensis biovar 3 were compared using B. abortus S99, B. melitensis M1, M2 and M3 antigens in the Rose Bengal plate test (RBPT), the complement fixation test (CFT) and an enzyme-linked immunosorbent assay (ELISA) test. Forty-six sheep from an officially brucellosis-free flock were experimentally infected intraconjunctivally with B. melitensis biovar 3. Prior to infection, all animals were tested first against Brucella antibodies, weekly for 2 months post-infection (PI) and then monthly for a further 7 1 2 months. All sera were tested against the antigens listed above using RBPT, CFT and ELISA. Using a Bayesian approach, test sensitivities were estimated and compared. Their ability for the early detection of antibodies was evaluated through a regression model based on a logit response model, using the number of days PI as the independent variable and the logit of the fraction of positive animals as the dependent variable. No significant differences were detected among the various antigens used, either in terms of sensitivity or in terms of antibody kinetics; however, the CFT was significantly less sensitive than the RBPT and ELISA and it also showed a lower rate of increase of percentage positive animals (b-coefficient of regression analysis). Introduction The serological diagnosis of Brucella melitensis infection, in the European Union (EU), is performed using the B. abortus biovar 1 strains Weybridge S99 or USDA 1119-3 heterologous antigen (EC, 2). The officially recognized tests are the complement fixation (CFT) and Rose Bengal Plate (RBPT) test (O.I.E., 2). In Europe, the enzyme-linked immunosorbent assay (ELISA) is not used officially for the diagnosis of brucellosis in sheep and goats. In a previous study (Nannini et al., 1992), the ability of antigen S99 to detect antibodies in 3 sheep experimentally infected with B. melitensis biovar 2 was found to be satisfactory [1 and 97% positive to RBPT and CFT, respectively, 1 month post-infection (PI) which decreased to 97 and 83% 6 months PI]. Despite the satisfactory results using the S99 antigen, Corbel (1985) suggested that, in the final phase of an eradication programme, a homologous antigen may prove more useful as it might detect antibodies earlier and be also more sensitive than a heterologous antigen. In a study (Alton et al., 1971) using sera obtained from cattle, rabbit, goat and human beings infected with various strains of B. abortus and B. melitensis, the performances of three antigens prepared from B. abortus, B. suis and B. melitensis, were compared in the tube agglutination test. All sera were strongly positive, but in most instances the titre was higher when using the homologous than the heterologous antigen. A later study (Corbel, 1985), indicated that the use of the M antigen (derived from B. melitensis biovar 1) in the RBPT, when testing cattle infected with an M-dominant strain of B. abortus (biovar 5), performed better than the classical A-dominant antigen. In another study (Connell and Dubray, 1986) on the standardization of RBPT for the diagnosis of B. melitensis infection in sheep and goats, a higher sensitivity was observed with the B. abortus S99 antigen than with the B. melitensis antigens. Using sheep experimentally infected with B. melitensis biovar 3, this study compares the performance of antigens prepared with B. abortus S99, B. melitensis M1, M2 and M3 using the RBPT, CFT and ELISA tests. Material and Methods Animals Forty-six brucellosis-free Fabrianese and cross-bred ewes, aged between 1 and 5 years, and of which 26 were pregnant, were experimentally infected intraconjunctivally with a field strain of B. melitensis biovar 3. A freshly isolated field strain was inoculated into two guinea pigs and re-isolated from their spleens 21 days later in 1 ml of Farrel s medium. After 48 h of growth in medium at 37 C, the re-isolated Brucella was titrated. A dose of 5 1 8 colony-forming units (CFU) in 1 ll was inoculated into the conjuctiva of both eyes (5 ll each) of the experimental ewes according to the provisions of the European Pharmacopoeia (Conseil de l Europe, 2). Sampling All animals were tested for Brucella antibodies prior to experimental infection and, once infected, were tested for the following 9 1 2 months, according to the protocol given in Table 1. A total of 648 sera were collected and tested by RBPT, CFT and ELISA, using the four antigens listed above. U. S. Copyright Clearance Center Code Statement: 931 1793/25/522 75$15./ www.blackwell-synergy.com

76 M. Tittarelli et al. Table 1. Sampling protocol for experimentally Brucella-infected sheep Sampling no. Date Dpi Sampled animals 1 16/6/1999 46 2 25/6/1999 9 46 3 1/7/1999 15 45 4 8/7/1999 22 45 5 16/7/1999 3 45 6 22/7/1999 36 44 7 29/7/1999 43 44 8 5/8/1999 5 43 9 12/8/1999 57 44 1 2/1/1999 126 43 11 9/2/2 238 39 12 27/3/2 285 41 Dpi, days PI. Serological testing The four antigens were prepared in the Istituto Zooprofilattico Sperimentale dell Abruzzo e del Molise, using B. abortus biovar 1 strain S99, B. melitensis biovar 1 strain 16/M, B. melitensis biovar 2 strain 63/9 and B. melitensis biovar 3 strain Ether, all provided by the Veterinary Laboratories Agency (Weybridge, UK). Whole cell antigens for RBPT and CFT were prepared and tests performed following Alton et al. (1988). Smooth lipopolysaccharide (LPS) ELISA antigens were extracted following Hendry et al. (1985) and the tests performed following set standards for diagnostic tests and vaccines (O.I.E., 2). Statistical analyses Sensitivity values for both tests and antigens were estimated and compared using a Bayesian approach (Sivia, 1996). of the various possible sensitivity values were estimated using a binomial likelihood function and an uninformed Uniform(,1) prior distribution. A group of posterior b-distributions was calculated for the entire experimental period (using all 62 sera derived from repeated sampling of the 46 animals). As the use of repeated sampling data introduces a dependency in the data set, the following two cross-sections were considered: (i) the first month after infection (i.e. the 45 sera collected 3 days PI) and (ii) the last sampling performed 9 1 2 months PI (i.e. 39 sera collected 285 days PI). Similar probability distributions were calculated using data from a previous study (Nannini et al., 1992) in which 3 sheep had been infected with B. melitensis biovar 2 and tested using S99 antigen in RBPT, CFT and ELISA; only the samples collected by Nannini et al. (1992) 35 days PI are assessed in the present analysis. The Bayesian analysis was performed using MS-Excel for Windows. The CFT antibody titres obtained using the four antigens were compared by Friedman s non-parametric analysis of variance and the contrasts were evaluated using the Wilcoxon test (Siegel and Castellan, 1988). The ability for early antibody detection was evaluated using a logit response model (Norusˇ is, 1997); the number of days PI was the independent variable and the logit of the fraction of positive animals was the dependent variable. These latter two analyses were performed using SPSS for Windows (version 12.). Results All animals were negative for brucellosis before infection. All except one of the pregnant ewes aborted during the last month of pregnancy; B. melitensis was isolated from either the liver, the abomasum or from the brain of the aborted foetuses. Five animals died during the experiment, one as a sequel to the abortion; the remainder died of causes unrelated to brucellosis between 2 weeks and 8 months PI. The respective results obtained using the RBPT, the CFT and the ELISA are compared in Table 2. These sensitivity values reflect two phases of infection in the animals: the first phase is one of steeply increasing antibody production (lasting approximately 1 month), and the second phase of more stable antibody production. During the first month, and using all antigens, test sensitivities showed little increase in the first 9 days PI, the values ranging between and 4%, but reached 1% on the 36th day PI in both the ELISA and the RBPT and only on the 5th day in the CFT (Table 2). Following the 5th day PI, all test sensitivities stood at 1%. As a result of the antibody kinetics, different test sensitivities should be calculated for the two phases of infection: (i) the first month PI and (ii) the remaining period up to 1 year PI. The probability distributions of the estimates of sensitivity for the 3th day PI are shown in Fig. 1 and for the last day of PI in Fig. 2. All 12 samplings were also considered together; the resulting probability distributions of the estimates are shown in Fig. 3. These Dpi Animals tested RBPT (%) CFT (%) ELISA (%) S99 M1 M2 M3 S99 M1 M2 M3 S99 M1 M2 M3 46 9 46 2 2 2 2 2 4 2 15 45 58 71 73 4 29 14 11 14 49 44 42 44 22 45 91 87 96 93 49 45 55 55 93 91 93 93 3 45 1 96 1 93 82 64 77 77 98 1 98 1 36 44 1 1 1 1 98 95 98 1 1 1 1 1 43 44 1 1 1 1 95 95 98 95 1 1 1 1 5 43 1 1 1 1 1 1 1 1 1 1 1 1 57 44 1 1 1 1 1 98 1 1 1 1 1 1 126 43 1 1 1 1 1 98 1 1 1 1 1 1 238 39 1 1 1 1 1 97 95 97 1 1 1 1 285 41 1 1 1 1 1 95 1 95 1 1 1 1 Table 2. Results obtained in 12 samplings with the RBPT, CFT and ELISA tests and S99, M1, M2, M3 antigens Dpi, days PI.

Serological Diagnosis of Brucellosis 77 S99 and M2 M1 M3 S99 M1 M2 and M3 S99 and M2 M1 and M3.4 RBPT 3 d.p.i..8 CFT 3 d.p.i..4 ELISA 3 d.p.i..7.3.6.3.4.3.1.2.1.1 3 5 7 9 3 5 7 9 3 5 7 9 Fig. 1. distributions of the estimates of sensitivity of serological tests for brucellosis 3 days PI. All antigens S99 M2 M1 and M3 All antigens RBPT 285 d.p.i. CFT 285 d.p.i. ELISA 285 d.p.i..3.3.3.2.2.2.1.1.1 8 85 9 95 1 8 85 9 95 1 8 85 9 95 1 Fig. 2. distributions of the estimates of sensitivity of serological tests for brucellosis 285 days PI. indicate that the sensitivity of the RBPT ranged between 87 and 9% depending upon the antigen used (S99 ¼ 89%, M1 ¼ 89%, M2 ¼ 9%, M3 ¼ 87%), that of the CFT ranged between 81 and 84% (S99 ¼ 84%, M1 ¼ 81%, M2 ¼ 82%, M3 ¼ 82%), and that of the ELISA was a consistent 88% for all antigens. The results of the 46 animals tested on the first sampling (day ) can be used to estimate test specificity (Fig. 4). The probability distribution of sensitivity estimates obtained in a previous study (Nannini et al., 1992) and shown in Fig. 5, are used to compare the performance of S99 antigen in B. melitensis biovar 2 and in biovar 3 infections. If each of the three tests is examined separately, and antigen performances are compared, it will be seen that all curves overlap. The overlap of areas below the 3-day PI curves (Fig. 1) is between 26% and 1% in the case of RBPT, between 18 and 1% for CFT and between 63% and 1% for ELISA. At the end of the experiment (285 days PI, Fig. 2), the overlap had increased to 1% for all antigens using both the RBPT and the ELISA, but was lower (ranging between 41% and 1%) when using the CFT. The amount of overlap in the distributions indicates the similarity of the probability of the test sensitivities. The test performances for each of the three B. melitensis antigens indicate the CFT to be of lower sensitivity when compared with RBPT and ELISA using the 3-day PI data (Fig. 6). These differences decrease over increasing PI period and disappear 5 days PI when all animals tested positive in all

78 M. Tittarelli et al. S99 M1 M2 M3 S99 M1 M2 and M3 S99 M1 and M2 M3 RBPT 12 samplings CFT 12 samplings ELISA 12 samplings.3.3.3.2.1.1.1 7 8 9 1 7 8 9 1 7 8 9 1 Fig. 3. distributions of the estimates of sensitivity of serological tests for brucellosis in all 12 serum samples..45.4.35.3.25.2.15.1 5 8 82 84 86 88 9 Specificity (%) 92 94 96 98 1 Fig. 4. distribution of the specificity based on 46 uninfected sheep..1 RBPT CFT ELISA 6 65 7 75 8 85 9 95 1 Fig. 5. distribution of sensitivity estimates of serological tests for brucellosis using S99 antigen in 3 sheep experimentally infected with Brucella melitensis biovar 2 (Nannini et al., 1992). tests using all antigens (Table 2). One week thereafter and subsequently, very few negative CFT results were obtained using the various M antigens (Table 2). The CFT antibody titres differed significantly amongst all four antigens both 3 days PI (v 2 ¼ 48., P < 1) and 285 days PI (v 2 ¼ 64.4, P < 1) using Friedman s non-parametric analysis of variance. In these two sample collection days, the titres were significantly higher to antigen S99 than to any of the three M antigens (Wilcoxon test, P < 1). The antibody kinetics during the first 2 months, which is expressed as the percentage of animals positive at each sampling point, are shown in Fig. 7. The dots in the figure represent the observed percentages, while the solid lines represent the expected percentages based on the logit response analysis. If the four antigens are compared, no statistically significant differences occur. However, the antibody response appears earlier in the RBPT and in the ELISA than in the CFT. The difference in the observed antibody responses is statistically significant except for the RBPT CFT (using antigen M3) and the CFT ELISA (using antigen M2) (Fig. 8). Discussion Under the experimental conditions described in this paper, homologous antigens did not give a more sensitive result than

Serological Diagnosis of Brucellosis 79.4.3.1 Antigen S99 3 d.p.i. 4 5 6 7 8 9 1.4.3.1 Antigen M2 3 d.p.i. 4 5 6 7 8 9 1 RBT S99 CFT S99 ELISA S99 RBT M2 CFT M2 ELISA M2.4.3.1 Antigen M1 3 d.p.i. 4 5 6 7 8 9 1.4.3.1 Antigen M3 3 d.p.i. 4 5 6 7 8 9 1 RBT M1 CFT M1 ELISA M1 RBT M3 CFT M3 ELISA M3 Fig. 6. Comparative performance of RBPT, CFT and ELISA 3 days PI. RBPT-antibody kinetics CFT-antibody kinetics ELISA-antibody kinetics 1 1 1 9 9 9 Percent positive animals 8 7 6 5 4 3 obs S99 exp S99 obs M1 exp M1 obs M2 exp M2 obs M3 exp M3 Percent positive animals 8 7 6 5 4 3 obs S99 exp S99 obs M1 exp M1 obs M2 exp M2 obs M3 exp M3 Percent positive animals 8 7 6 5 4 3 obs S99 exp S99 obs M1 exp M1 obs M2 exp M2 obs M3 exp M3 2 2 2 1 1 1 2 4 6 Days post-infection 2 4 6 Days post-infection 2 4 6 Days post-infection Fig. 7. Antibody kinetics during the first 2 months after experimental infection with Brucella melitensis biovar 3. that obtained using the standard antigen (S99) for detecting B. melitensis infections in sheep. Furthermore, they do not appear capable of detecting infections earlier, thus contradicting the findings of earlier authors (Alton et al., 1988; Corbel, 1985; Connell and Dubray, 1986). The current findings using the RBPT and the ELISA cannot be compared directly against those obtained by Alton et al. (1988) as the tube agglutination test used for antigen comparison in that study is quantitative, whereas the RBPT and the ELISA are both qualitative. The only possible comparison

8 M. Tittarelli et al. Regression coefficients and 95% Cl.9.8.7.6.5.4.3.2.1 RBT S99 RBT M1 RBT M2 RBT M3 CFT S99 CFT M1 CFT M2 CFT M3 ELISA S99 ELISA M1 ELISA M2 ELISA M3 Fig. 8. Regression of the logit of the fraction of animals positive to Brucella antibodies and the number of days PI. that can be made is with our CFT results. All the sera tested by Alton et al. (1988) gave positive results against all antigens, and agrees with the similar sensitivity values obtained by us. However, Alton et al. (1988) had a titre generally higher using the homologous antigen; this finding contrasts against the significantly higher CFT titres obtained by us using the heterologous antigen S99 (when compared with the homologous M antigens). Corbel (1985) found that the M antigen (derived from B. melitensis biovar 1) used in the RBPT was more sensitive when testing cattle infected with an M-dominant strain of B. abortus (biovar 5). He claimed a significant result (P < 1) when he applied chi-square analysis in the RBPT performed manually on 173 field sera. Actually, the difference amounted to 43 discordant sera (21 of which were positive to the A antigen and negative to the M antigen, and 22 the reverse). Corbel s remaining 166 sera were either consistently negative (1581 sera) or positive (79 sera) to both antigens. A McNemar chi-squared test performed by us on his results did not revealed any statistically significant difference (v 2 ¼ ; P ¼ 1). The results obtained in this study also differ from the findings of Connell and Dubray (1986) who, in an attempt to standardize the RBPT for the diagnosis of B. melitensis infection in sheep and goats, observed a higher sensitivity when using the B. abortus S99 antigen than when using the B. melitensis antigen. The study, based on the repeated testing of the same 31 sera from infected flocks (15 repetitions for each serum and made by five independent laboratories) indicates that the S99 antigen performed best with 82.7% of positive results; however, the data were not statistically analysed and only tables summarizing the data were presented, thus impairing a statistical comparison with our results. Results similar to ours, and so indicating similar sensitivities for homologous and heterologous antigens, were obtained by Alonso-Urmeneta et al. (1998). A possible explanation for the similar sensitivity values with homologous and heterologous antigens may be found in the excess amounts of both A and M antigens used in relation to the amounts actually required for a serological reaction. This excess could induce an antibody response to all antigens involved, with the possible dominance of antibodies against common epitopes (Alonso-Urmeneta et al., 1998). As regards the sensitivity of the S99-RBPT 1 month PI, our results agree with those reported in a previous study (Nannini et al., 1992) as no relevant differences could be detected in the respective probability distributions in the two studies. The wider range in distributions observed in the earlier study (Nannini et al., 1992) is because of the lower number of sera examined (3 versus 46). However, the sensitivity of the S99-CFT antigen was lower in this study (Nannini et al., 1992), but the biological significance of this finding is uncertain because of a one animal being found negative 1 month PI and then becoming positive upon subsequent samplings. Although an experimental infection might be considered a simplification of the real world, this long-term study, with a high frequency of samplings in the initial phases of the infection cycle, allows us to make some inferences on possible in-field infection scenarios. With experimental infection the principal simplification is that all animals are infected simultaneously. Estimates of test sensitivity are, therefore, influenced heavily by the time intervals between infection and sampling. Sensitivity is usually calculated at the point where the antibody curve reaches a plateau and is expressed usually by sensitivity distributions as shown in Fig. 2. This approach is correct in terms of evaluating the performance of the test under optimal conditions, but may be misleading under field conditions. In the Mediterranean region where the transhumant breeding of sheep is extensive, a certain degree of pregnancy synchronization is practiced with lambing usually occurring before the animals move to their summer pastures. Most of the serological testing in these instances is performed either before the animals depart for their summer pastures (i.e. a few months after the lambing season) or when the flocks return to their winter residences. However, and especially in southern Europe, tests may be performed twice, once in each period. Under such conditions, and during the spring testing period, a number of animals will be in the initial stages of infection and, therefore, probability distributions of sensitivity similar to those in Fig. 1 can be expected. However, during the autumn testing, when several months would have elapsed since the peak of brucellosis dissemination (i.e. during the lambing season), the probability distributions of sensitivity will be more similar to those shown in Fig. 2. Further studies are required to evaluate

Serological Diagnosis of Brucellosis 81 the sensitivity of the tests when a longer period has elapsed following experimental infection. For this reason, the present study will be continued into the second year PI, and following a second pregnancy. Under EU regulations set out in Annex A of Directive 91/68/CEE (EC, 1991) sheep and goat flocks that have been declared officially brucellosis-free, maintain their status even when only 25% of the adult females have been tested. If this testing protocol is used on three flocks of 1 sheep each with respective infection rates of 2, 3 and 4%, the respective probabilities of no infected sheep being detected will be 25, 12 and 6%. The present study indicates that such probability levels will be raised further by the sub-optimal performances of tests used in recently infected animals. It would be reasonable, therefore, for the regulation to be amended so that all animals in transhumant flocks be tested as they often share a common summer pasturage, thus increasing the risk of brucellosis transmission. Acknowledgements We are grateful to Arcangelo Di Matteo and Diamante Rodomonti for their expert assistance in the serological assays and to Rudy Meiswinckel for his much appreciated help in revising the paper. References Alonso-Urmeneta B., C. Marín, V. Arago` n, J. M. Blasco, R. Díaz, and I. Moriyòn, 1998: Evaluation of lipopolysaccharides and polysaccharides of different epitopic structures in the indirect enzymelinked immunosorbent assay for diagnosis of brucellosis in small ruminants and cattle. Clin. Diagn. Lab. Immunol. 5, 749 754. Alton G. G., 1971: Standardization of agglutinating antigens for the diagnosis of brucellosis. Res. Vet. Sci. 12, 33 337. Alton G. G., L. M. Jones, R. D. Angus, and J. M. Verger, 1988: Techniques for the Brucellosis Laboratory. I.N.R.A., Paris. Connell J., and G. Dubray, 1986: Standardization of Rose Bengal Plate Test and Allergic Skin Test for Diagnosis of Brucella melitensis Infection in Sheep and Goats. E.C.R.N. B. melitensis. Report 3. Commission of the European Communities Scientific Workshop, Brussels, 2 21 November 1986. Conseil de l Europe 2: Pharmacopée Européenne. Cinquième e dn. pp. 2459 246. Conseil de l Europe, Strasbourg, France. Corbel M. J., 1985: Comparison of Brucella abortus and B. melitensis antigens for the Rose Bengal plate test on sera from cattle infected with B. abortus biovar 5. Vet. Rec. 117, 385 386. EC, 1991: Council Directive 91/68/EEC of 28 January 1991 on animal health conditions governing intra-community trade in ovine and caprine animals. EC Official J. L 46, 19 36. EC, 2: Commission Decision 2/33/EC of 18 April 2 approving tests for the detection of antibodies against bovine brucellosis within the framework of Council Directive 64/432/EEC (notified under document number C(2) 142) (text with EEA relevance). EC Official J. L 114, 37. Hendry D. M. F. D., M. J. Corbel, R. A. Bell, and J. A. Stack, 1985: Brucella Antigen Production and Standardization. Central Veterinary Laboratory New Haw, Weybridge. Nannini D., A. Giovannini, M. Tittarelli, E. Di Giannatale, P. Semprini, V. Caporale, D. Cerri, E. Andreani, and R. Farina, 1992: Valutazione della risposta anticorpale in pecore sperimentalmente infettate con B. melitensis biovariante 2. Vet. It. 28, 4 1. Norusˇ is M. J., 1997: SPSS Professional Statistics 7.5. SPSS Inc., Chicago, IL, USA. O.I.E. 2: Manual of Standards for Diagnostic Tests and Vaccines. Fourth edition. pp. 475 489. O.I.E., Paris, France. Siegel S., and Castellan N. J. 1988: Non Parametric Statistics for the Behavioral Sciences, 2nd edn. Mc Graw-Hill Book Co., New York, USA. Sivia D. S. 1996: Data Analysis. A Bayesian Tutorial. Clarendon Press, Oxford, UK.